C07D 295/14
Substituted by carbon atoms having three bonds to hetero atoms with at
Official title: substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D295/14 (Substituted by carbon atoms having three bonds to hetero atoms with at) appears on 1,808 US grants and 1,615 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,808
- Published applications
- 1,615
- Assignees
- 888
- Inventors
- 5,671
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 28 | 0 |
| 1977 | 35 | 0 |
| 1978 | 31 | 0 |
| 1979 | 25 | 0 |
| 1980 | 27 | 0 |
| 1981 | 34 | 0 |
| 1982 | 20 | 0 |
| 1983 | 21 | 0 |
| 1984 | 35 | 0 |
| 1985 | 19 | 0 |
| 1986 | 23 | 0 |
| 1987 | 20 | 0 |
| 1988 | 17 | 0 |
| 1989 | 21 | 0 |
| 1990 | 16 | 0 |
| 1991 | 16 | 0 |
| 1992 | 18 | 0 |
| 1993 | 24 | 0 |
| 1994 | 27 | 0 |
| 1995 | 27 | 0 |
| 1996 | 23 | 0 |
| 1997 | 34 | 0 |
| 1998 | 35 | 0 |
| 1999 | 34 | 0 |
| 2000 | 29 | 0 |
| 2001 | 50 | 10 |
| 2002 | 48 | 53 |
| 2003 | 40 | 69 |
| 2004 | 46 | 89 |
| 2005 | 35 | 75 |
| 2006 | 41 | 72 |
| 2007 | 44 | 78 |
| 2008 | 32 | 72 |
| 2009 | 55 | 81 |
| 2010 | 50 | 66 |
| 2011 | 46 | 65 |
| 2012 | 51 | 67 |
| 2013 | 72 | 69 |
| 2014 | 60 | 86 |
| 2015 | 69 | 69 |
| 2016 | 59 | 77 |
| 2017 | 70 | 66 |
| 2018 | 39 | 41 |
| 2019 | 44 | 51 |
| 2020 | 35 | 52 |
| 2021 | 35 | 46 |
| 2022 | 40 | 57 |
| 2023 | 31 | 53 |
| 2024 | 33 | 61 |
| 2025 | 29 | 51 |
| 2026 | 15 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Amyloid targeting agents and methods of using the same22 Sep 2026US 12,741,949 B2Amydis, Inc.
- N-heteroarylalkyl-2-(heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists22 Sep 2026US 12,741,957 B2Takeda Pharmaceutical Company Limited
- Compound, corrosion inhibitor, and lubricant composition15 Sep 2026US 12,735,393 B2Idemitsu Kosan Co., Ltd.
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- Process for the preparation of sulfamoylbenzoic acid derivatives1 Oct 2026US 2026/0297022 A1Iama Therapeutics S.R.L.
- Sulfoximine compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same1 Oct 2026US 2026/0297073 A1Chong Kun Dang Pharmaceutical Corp.
- Novel mitofusin inhibitors17 Sep 2026US 2026/0274810 A1Albert Einstein College of Medicine
Most cited
By later US patents
- Apoptosis promoters226US 7,390,799 B2Abbott Laboratories · 2008
- Deacetylase inhibitors168US 6,552,065 B2Novartis AG · 2003
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Ligands for metals and improved metal-catalyzed processes based thereon143US 6,307,087 B1Massachusetts Institute of Technology · 2001
- Medicaments for the treatment of disorders of lipometabolism and their use138US 4,405,644 ABayer Aktiengesellschaft · 1983